These data strongly suggested that the specific amino acid sequences of both CPB and GBVA10-9 peptides were the major determinant of the peptide-mediated uptake of the fluorescent streptavidin bioconjugate by hepatoma cells. The gene discussed is CPB1; the disease is hepatocellular carcinoma.